tenet
immun
system
protect
host
invad
pathogen
autoimmun
diseas
aris
genet
suscept
individu
former
essenti
mount
robust
immun
respons
tcellmedi
immun
antibodi
product
myriad
pathogen
elimin
sourc
foreign
antigen
determin
adapt
immun
respons
must
contriv
restor
normal
clonal
bcell
repertoir
activationinduc
cell
death
apoptosi
credit
restor
clonal
size
primarili
antigenactiv
lymphocyt
end
product
immun
respons
failur
result
overt
immun
respons
caus
harm
benefit
host
exampl
overt
immun
respons
caus
damag
endogen
tissu
product
multipot
noxiou
cytokin
tumor
necrosi
inflammatori
condit
includ
sepsi
addit
need
control
adapt
immun
respons
autoimmun
respons
need
kept
check
minim
elimin
advers
reaction
host
tissu
lymphocyt
systemat
control
seemingli
opposit
version
immun
respons
variou
regulatori
mechan
involv
control
autoimmun
diseas
subject
intens
investig
mani
decad
among
known
autoimmun
diseas
specif
direct
central
nervou
system
cn
although
evid
involv
autoimmun
mani
cn
disord
weak
nonexist
indic
autoimmun
exist
case
neuromyel
optica
nmo
autoimmun
demyelin
disord
cn
typic
clinic
manifest
optic
neuriti
acut
transvers
myeliti
attack
although
nmo
believ
variant
ms
consid
independ
disord
nmo
character
presenc
antibodi
water
channel
protein
myelin
oligodendrocyt
glycoprotein
mog
characterist
phenotyp
disrupt
astrocyt
function
demyelin
spinal
cord
optic
nerv
particular
brain
region
lack
selftoler
water
channel
protein
like
caus
nmo
howev
underli
pathogen
mechan
fulli
elucid
alzheim
diseas
character
dementia
immunoglobulin
brain
parenchyma
deposit
complement
compon
neuron
autoimmun
enceph
group
disord
character
autoantibodi
direct
synapt
surfac
antigen
nmda
ampatyp
glutam
receptor
gaba
b
receptor
result
sever
neurolog
symptom
antibodi
glutam
acid
decarboxylas
ratelimit
enzym
gaba
synthesi
associ
autoimmun
neurolog
syndrom
name
stiff
person
syndrom
cerebellar
ataxia
epilepsi
limbic
enceph
abnorm
eye
movement
wherea
characterist
indic
underli
autoimmun
detail
studi
requir
fulli
understand
autoimmun
natur
diseas
importantli
regulatori
mechan
use
control
diseas
importantli
pauciti
experiment
model
dissect
immunolog
mechan
involv
variou
neurolog
disord
multipl
sclerosi
ms
wellcharacter
neuron
disord
underli
autoimmun
basi
whether
ms
nonimmunolog
disord
primarili
neurodegen
diseas
unknown
etiolog
heavili
debat
year
account
variou
tcell
toler
mechan
involv
immun
respons
nomin
antigen
selfdetermin
includ
neuron
antigen
describ
previous
review
ref
chapter
focu
ms
anim
model
experiment
autoimmun
encephalomyel
eae
highlight
underli
common
regulatori
mechan
point
dispar
system
final
discuss
limit
data
obtain
variou
eae
model
translat
clinic
practic
treatment
differ
form
ms
ms
chronic
diseas
last
mani
decad
highli
variabl
present
initi
diagnosi
clinic
isol
syndrom
major
patient
display
common
relapsingremit
form
ms
year
diagnosi
untreat
patient
develop
secondari
progress
ms
wherea
patient
diseas
progress
without
remiss
refer
primari
progress
ms
current
treatment
direct
relapsingremit
ms
none
effect
primari
secondari
progress
ms
drug
direct
cull
autoimmun
compon
wherea
modal
treat
neurodegen
compon
ms
scarc
cn
immunolog
privileg
site
lack
potent
innat
immun
respons
healthi
individu
immun
cell
infiltr
across
bloodbrain
barrier
bbb
promot
inflamm
demyelin
gliosi
neuroaxon
degener
result
disrupt
neuron
signal
better
understand
impact
tcell
toler
ms
knowledg
critic
underli
patholog
featur
vital
ms
thought
mediat
tcell
although
cell
antibodyproduc
b
cell
known
contribut
diseas
pathogenesi
cnsintrins
event
activ
microglia
astrocyt
well
chemokin
also
implic
ms
autoreact
lymphocyt
thought
mount
aberr
immun
respons
cn
autoantigen
suscept
develop
ms
link
class
ii
human
leukocyt
antigen
allel
express
antigenpres
cell
impli
role
distinct
antigen
present
lymphocyt
necessari
diseas
induct
although
etiolog
ms
unknown
poorli
understood
stochast
event
environment
factor
influenc
diseas
penetr
infiltr
immun
cell
peripheri
promin
relapsingremit
ms
cell
appear
earli
lesion
format
inflamm
brain
spinal
cord
evid
ms
patient
declin
age
durat
diseas
open
question
whether
ms
trigger
peripheri
drain
lymph
node
origin
cn
peripher
lymphocyt
specif
neuron
antigen
thought
activ
molecular
mimicri
subsequ
reactiv
cn
resid
antigenpres
cell
lead
cascad
event
result
neuron
damag
although
specif
autoreact
cell
ms
remain
obscur
recognit
autoantigen
mog
myelin
basic
protein
mbp
lymphocyt
healthi
individu
ms
patient
demonstr
rel
frequenc
cell
healthi
individu
ms
case
remain
contenti
thu
clear
whether
observ
selfreact
lymphocyt
ms
patient
reflect
underli
patholog
event
stochast
event
result
molecular
mimicri
breach
selftoler
although
earlier
studi
implic
produc
cell
sole
pathogen
cell
recent
investig
also
support
role
cell
express
found
peripher
blood
cn
cerebrospin
fluid
csf
ms
patient
furthermor
th
cell
mix
phenotyp
doubleproduc
express
interleukin
higher
capac
infiltr
cn
infer
studi
postmortem
ms
brain
tissu
result
indic
pivot
role
doubl
produc
ms
pathogenesi
interestingli
cell
found
activ
lesion
ms
patient
produc
similar
mucosalassoci
invari
cell
addit
consist
particip
cell
b
cell
propos
strong
candid
autoimmun
effector
cell
ms
although
signific
differ
b
cell
found
csf
neither
predict
diseas
diseas
progress
edss
expand
disabl
statu
scale
convers
clinic
definit
ms
follow
diagnosi
clinic
isol
syndrom
ms
patholog
character
confluent
demyelin
area
known
plaqu
lesion
white
gray
matter
brain
spinal
cord
indic
loss
myelin
sheath
oligodendrocyt
damag
axon
neuron
correl
diseas
sever
astrocyt
form
multipl
sclerot
glial
scar
white
matter
lesion
demyelin
gray
matter
cortex
nuclei
spinal
cord
also
associ
ms
inflamm
pronounc
acut
chronic
phase
invad
immun
cell
macrophag
indic
bbb
leakag
macrophag
cell
cell
b
cell
plasma
cell
repres
descend
proport
earli
stage
littl
damag
outsid
plaqu
call
normalappear
white
matter
present
brain
spinal
cord
despit
gener
brain
atrophi
diseas
progress
diffus
tcell
bcell
infiltr
microglia
astrocyt
activ
diffus
myelin
reduct
axon
damag
evid
although
number
cell
chang
frequenc
b
cell
plasma
cell
increas
wherea
microglia
macrophag
remain
chronic
state
activ
throughout
diseas
secondari
progress
ms
tertiari
lymphoid
structur
evid
mening
contribut
cortic
demyelin
tissu
damag
later
stage
earliest
descript
eae
occurr
acut
dissemin
encephalomyel
monkey
repeatedli
given
intramuscular
inject
normal
rabbit
brain
emuls
extract
observ
explain
induct
encephalomyel
observ
earlier
human
vaccin
rabi
viru
grown
rabbit
spinal
cord
due
immun
respons
trigger
spinal
cord
contamin
vaccin
sinc
monophas
eae
induc
guinea
pig
rat
mice
primat
immun
spinal
cord
homogen
peptid
deriv
mog
mbp
plp
see
ref
citat
complet
freund
adjuv
along
pertussi
toxin
requir
eae
induct
guinea
pig
rat
mice
howev
incomplet
adjuv
without
mycobacterium
tuberculosi
suffici
induc
eae
strain
rat
marmoset
interestingli
eae
could
induc
suscept
rat
strain
dark
agouti
without
pertussi
toxin
sever
explan
put
forward
includ
breach
bbb
break
selftoler
enhanc
immunogen
inoculum
explain
depend
pertussi
toxin
eae
induct
although
question
rais
valid
result
obtain
eae
model
translat
treatment
ms
patient
argument
also
made
support
fact
use
wise
eae
provid
benefici
inform
clinic
applic
rodent
eae
model
character
ascend
flaccid
paralysi
reflect
preferenti
target
inflamm
spinal
cord
refer
classic
eae
manifest
differ
form
immun
immunodomin
peptid
induc
mild
monophas
form
eae
strain
haplotyp
model
clinic
symptom
peak
around
day
immun
follow
spontan
resolut
day
howev
patholog
monophas
eae
mice
parallel
ms
form
contrari
similar
immun
induc
longlast
day
ref
sever
diseas
nod
mice
character
paralysi
fore
hind
limb
without
discern
remiss
respect
repres
secondari
primari
progress
ms
regardless
nod
mice
eae
occur
high
frequenc
share
uniqu
featur
ms
includ
lifelong
diseas
promin
demyelin
axon
loss
astrogliosi
hand
immun
peptid
induc
relapsingremit
eae
sjlj
mice
character
appear
clinic
sign
day
prime
relaps
first
appear
day
common
classic
eae
induc
variou
peptid
antigen
mice
inflamm
preferenti
target
spinal
cord
small
number
antigenspecif
model
brain
rather
spinal
cord
select
target
refer
atyp
eae
initi
observ
mice
immun
peptid
confirm
subsequ
knockout
balbc
mice
immun
mbp
peptid
mice
immun
mog
atyp
eae
present
movement
disord
propriocept
defect
ataxia
spastic
axial
rotat
head
trunk
character
predomin
cerebellar
brainstem
involv
variou
anim
model
use
gain
insight
underli
immunolog
mechan
variant
form
ms
howev
display
complex
variabl
clinic
featur
spontan
remiss
certain
model
render
interpret
result
difficult
sinc
variant
eae
recapitul
featur
ms
use
ascertain
efficaci
treatment
procedur
preclin
model
close
mimic
select
form
ms
question
model
demyelin
diseas
includ
viral
infect
administr
toxic
substanc
see
ref
citat
chronic
demyelin
encephalomyel
induc
intracrani
introduct
theiler
viru
bean
strain
daniel
strain
nasal
infect
mous
hepat
corona
viru
inflammatori
infiltr
consist
cell
activ
macrophagesmicroglia
cn
although
viral
model
may
reflect
critic
featur
mslike
inflammatori
inflamm
complic
involv
virusinduc
immunemedi
mechan
importantli
evid
role
virus
ms
pathogenesi
yet
obtain
demyelin
induc
toxic
model
use
cuprizon
copper
chelat
use
understand
mechan
demyelin
remyelin
fulli
reflect
aspect
ms
patholog
pathogenesi
although
role
cell
eae
well
establish
controversi
exist
ident
helper
subset
involv
wherea
cell
shown
crucial
earli
eae
cell
particip
later
stage
contrast
cell
doubl
produc
express
migrat
cn
arriv
cell
cell
lost
express
gain
clinic
diseas
manifest
studi
indic
cell
alon
could
mediat
eae
upon
adopt
transfer
mice
howev
contamin
variou
degre
cell
cell
prepar
rais
question
independ
role
cell
eae
manifest
primari
progress
eae
cell
found
spinal
cord
wherea
cell
cell
infiltr
spinal
cord
later
diseas
howev
cell
promin
peripher
lymphoid
tissu
plastic
cell
complic
role
distinct
helper
subset
eae
manifest
despit
enorm
effort
understand
role
variou
lymphokin
cytokin
accessori
cellassoci
determin
role
eae
pathogenesi
remain
obscur
although
cell
dub
encephalitogen
cell
neither
contribut
eae
cytokin
attribut
role
eae
gmcsf
primari
progress
eae
model
amelior
diseas
treatment
potent
histon
deacetylas
inhibitor
trichostatina
tsa
associ
repress
gmcsfproduc
cell
secondari
lymphoid
organ
cn
closer
analysi
indic
gmcsf
dispens
eae
induct
essenti
chronic
tissu
damag
neutrophil
accumul
brain
blockad
gmcsf
receptor
amelior
relaps
mice
lesion
secondari
progress
primari
progress
ms
patient
contain
gmcsf
receptor
myeloid
cell
indic
possibl
target
diseas
intervent
collect
data
suggest
essenti
role
gmcsf
effector
arm
inflammatori
diseas
ident
cytokin
crucial
induct
autoimmun
cn
diseas
remain
delin
patholog
mechan
vari
eae
model
acut
monophas
eae
character
multifoc
confluent
area
mononuclear
inflammatori
infiltr
demyelin
peripher
white
matter
spinal
cord
brain
addit
mening
perivascular
inflammatori
cuf
cerebellum
hindbrain
white
matter
promin
relapsingremit
eae
induc
immun
lesion
optic
nerv
brainstem
spinal
cord
cerebellum
cerebr
cortex
along
perivascular
mening
lymphocyt
neutrophil
filtrat
evid
besid
white
matter
damag
gliosi
demethyl
axon
observ
primari
progress
eae
induc
immun
nod
mice
inflammatori
cuff
around
dilat
blood
vessel
white
matter
penetr
gray
matter
observ
spinal
cord
acut
phase
diseas
chronic
phase
accompani
sever
damag
peripheri
numer
vacuol
dorsal
dorsolater
funiculu
inflammatori
cell
abund
white
gray
matter
subarachnoid
space
ventral
funiculu
luxol
fast
blue
stain
indic
sever
demyelin
neuron
spinal
cord
bielschowski
silver
impregn
method
unravel
lack
neurofila
white
gray
matter
indic
sever
axon
loss
form
eae
although
controversi
exist
whether
macrophag
play
pathogen
protect
role
classic
eae
increas
accumul
neutrophil
acut
phase
eae
evid
spinal
cord
mice
primari
progress
eae
featur
attribut
atyp
eae
thu
appear
patholog
mechan
involv
monophas
relapsingremit
primari
secondari
progress
eae
well
atyp
eae
remark
distinct
seem
overlap
autoreact
b
cell
delet
thymu
refer
central
toler
account
lack
overtli
selfreact
lymphoid
cell
appar
healthi
individu
howev
delet
mechan
absolut
fraction
selfreact
lymphocyt
escap
thymic
select
exit
peripheri
may
explain
presenc
cell
specif
mbp
peripher
blood
asymptomat
rel
ms
patient
similarli
mogspecif
cell
detect
peripher
blood
healthi
individu
albeit
lower
level
compar
ms
patient
follow
vitro
expans
mog
peptid
although
selfreact
cell
potenti
trigger
autoimmun
diseas
appropri
activ
antigen
present
elicit
autoimmun
healthi
peopl
due
restraint
impos
peripher
toler
mechan
although
reactiv
multipl
neuron
determin
mbp
mog
plp
demonstr
ms
ident
caus
autoantigen
involv
induct
diseas
remain
obscur
similarli
initi
autoantigen
autoimmun
diseas
includ
type
diabet
also
remain
unknown
lack
critic
inform
neg
impact
develop
success
antigenspecif
toler
strategi
manipul
ms
howev
util
toler
strategi
control
chronic
neurodegen
diseas
ms
remain
incomplet
understood
substanti
data
gener
eae
model
ms
support
role
immunoregulatori
cell
autoimmun
neurodegen
diseas
although
analog
tcellmedi
immunoregul
may
oper
ms
avail
data
limit
often
contenti
herein
discuss
data
critic
evalu
impact
ms
one
mechan
implic
prevent
autoimmun
diseas
tcell
anergi
physic
exist
cell
without
display
function
compet
exposur
clone
mous
cell
express
chemic
modifi
antigenpres
cell
puls
antigen
peptid
induc
state
unrespons
term
anergi
anerg
cell
unabl
produc
challeng
subsequ
unmodifi
antigenpres
cell
puls
specif
peptid
antigen
vitro
interestingli
form
toler
transient
sinc
activ
revers
anergi
restor
abil
anerg
cell
respond
antigenspecif
manner
subsequ
demonstr
peripher
blood
lymphocyt
reactiv
selfantigen
mbp
mog
asymptomat
rel
ms
patient
exemplifi
exist
potenti
autoreact
cell
absenc
overt
autoimmun
akin
anerg
cell
notabl
antigen
present
clone
murin
thymic
macrophag
induc
anergi
cell
without
requir
chemic
modif
indic
possibl
specif
nativ
antigenpres
cell
capabl
induc
anergi
despit
optim
express
costimulatori
determin
necessari
tcell
activ
howev
transient
revers
natur
tcell
anergi
impos
sever
restrict
appli
antigenspecif
toler
strategi
silenc
autoreact
cell
vivo
anoth
primari
mechan
peripher
toler
intens
studi
involv
particip
subset
antigenspecif
suppressor
ts
cell
govern
idiotypeantiidiotyp
interact
influenc
unresolv
genet
restrict
element
ij
ensu
result
suppress
antigenspecif
immun
respons
well
link
suppress
unrel
immun
respons
howev
lack
robust
biochem
molecular
evid
discourag
studi
antigendriven
ts
cell
declin
interest
antigenspecif
ts
cell
concept
regul
autoimmun
respons
lymphocyt
deriv
thymu
term
thymic
regulatori
ttreg
cell
emerg
also
subset
treg
cell
call
induc
treg
itreg
gener
activ
convent
cell
antigen
transform
growth
type
treg
cell
describ
relationship
treg
subset
antigenspecif
ts
cell
describ
earlier
well
rel
contribut
regul
immun
respons
nomin
antigen
autoimmun
remain
incomplet
understood
notion
immunoregul
accomplish
lymphocyt
distinct
convent
effector
cell
fuel
critic
observ
neonat
thymectomi
led
emerg
mani
autoimmun
diseas
mice
due
deplet
ttreg
cell
notabl
autoimmun
neuron
diseas
among
unleash
remov
ttreg
cell
ttreg
cell
enrich
tcell
receptor
exhibit
high
affin
selfpeptid
descript
critic
transcript
factor
develop
function
stabil
treg
cell
revit
studi
ttreg
cell
mice
well
human
wherea
ttreg
cell
control
autoimmun
diseas
itreg
cell
gener
convent
cell
low
affin
selfantigen
thought
play
promin
role
gener
immun
regul
although
three
treg
subset
treat
distinct
entiti
confirmatori
phenotyp
featur
distinguish
remain
unknown
although
treg
cell
also
exert
nonspecif
immun
suppress
similar
antigenspecif
ts
cell
molecular
natur
immunosuppress
remain
unclear
case
initi
human
counterpart
mous
treg
cell
identifi
thymu
peripher
blood
healthi
individu
cell
function
similar
mous
treg
cell
frequenc
phenotyp
function
treg
cell
extens
studi
ms
patient
studi
frequenc
treg
cell
peripher
blood
ms
patient
similar
healthi
individu
irrespect
diseas
activ
notabl
remov
receptor
cell
analysi
unravel
number
function
treg
cell
ms
patient
differ
healthi
individu
paradox
number
treg
cell
higher
cerebrospin
fluid
peripher
blood
ms
patient
chronic
ms
patient
higher
frequenc
memori
treg
cell
peripher
blood
surprisingli
treg
cell
also
significantli
increas
ms
patient
compar
healthi
individu
contrari
relapsingremit
ms
number
treg
cell
reduc
peripher
blood
interestingli
cell
express
lower
relaps
remiss
number
recent
thymic
emigr
treg
phenotyp
within
peripher
blood
declin
age
significantli
reduc
ms
patient
interestingli
treg
cell
express
ectoenzym
hydrolyz
atp
diminish
ms
patient
contrari
anoth
studi
frequenc
treg
cell
ms
patient
compar
healthi
control
date
littl
consensu
exist
phenotyp
frequenc
treg
popul
variou
clinic
form
ms
diseas
last
sever
decad
longitudin
analysi
treg
cell
use
uniform
phenotyp
marker
differ
stage
diseas
help
delin
whether
treg
cell
popul
correl
clinic
present
descript
master
regul
ttreg
cell
led
adopt
surrog
marker
mous
human
treg
cell
ipex
immun
regul
polyendocrinopathi
enteropathi
xlink
inherit
syndrom
character
diarrhea
diabet
mellitu
hemolyt
anemia
eczema
autodestruct
endocrin
gland
thyroid
absolut
evid
ms
ipex
syndrom
fatal
without
aggress
immunosuppress
bone
marrow
transplant
male
patient
rare
surviv
beyond
second
decad
life
although
insulindepend
diabet
diagnos
ipex
patient
associ
variat
gene
common
type
diabet
subsequ
found
ipex
associ
mutat
human
ortholog
gene
mutat
scurfi
mice
develop
autoimmun
disord
hand
ms
diagnos
clinic
isol
syndrom
typic
second
third
decad
life
requir
sever
decad
full
manifest
therefor
highli
unlik
ipex
patient
develop
full
spectrum
ms
symptom
within
two
decad
life
anoth
unexpect
complic
mutat
affect
treg
cell
also
effector
cell
indic
abil
cell
ipex
patient
suppress
prolifer
normal
autolog
respond
cell
thu
ipex
syndrom
associ
develop
resist
respond
cell
suppressor
signal
impair
suppressor
function
treg
cell
although
evid
link
ipex
syndrom
ms
share
similar
defect
function
treg
cell
like
serendipit
vide
infra
studi
experiment
model
unravel
role
treg
cell
immunoregul
complex
complic
spontan
cn
inflamm
observ
mutant
mice
target
deplet
treg
cell
wildtyp
mice
indic
loss
treg
function
alon
insuffici
caus
eae
paradox
group
observ
target
acut
deplet
treg
cell
result
limit
autoimmun
inflamm
control
effector
cell
prolifer
mobil
within
cn
indic
role
treg
cell
eae
regul
find
contrast
anoth
studi
show
treg
cell
accumul
cn
peak
eae
unabl
suppress
prolifer
cnsderiv
effector
cell
vitro
sever
studi
antibodi
administr
use
demonstr
particip
treg
cell
eae
interestingli
antibodi
administr
repress
secondari
primari
remiss
howev
bona
fide
marker
treg
cell
sinc
antibodi
persist
circul
extend
period
also
could
affect
activ
effector
cell
express
moreov
neither
administr
antibodi
adopt
transfer
treg
cell
obtain
resolut
monophas
eae
determin
antigenspecif
thu
analysi
requir
full
evalu
role
treg
cell
eae
mani
complic
imped
understand
role
treg
cell
eae
express
suffici
full
express
suppressor
phenotyp
requir
sever
partner
protein
includ
transcript
factor
nfat
influenc
treg
cell
function
critic
import
partner
protein
immunoregul
demonstr
report
nod
mice
disrupt
interact
cofactor
histon
acetyltransferas
histon
deacetylas
eo
acceler
develop
autoimmun
diabet
anoth
difficult
aspect
treg
cell
plastic
peripher
blood
ms
patient
increas
frequenc
secret
treg
cell
lower
suppress
abil
observ
indic
instabl
human
treg
cell
convers
treg
cell
cell
implic
pathogenesi
collageninduc
arthriti
mice
rheumatoid
arthriti
use
dual
lineag
trace
model
indic
convers
effector
treg
cell
central
treg
cell
accompani
increas
stabil
vivo
also
acquisit
treg
cell
express
activ
secret
report
although
treg
cell
appear
popul
specif
tissu
includ
muscl
skin
lung
gastrointestin
tract
involv
tissu
homeostasi
remain
specul
addit
complic
treg
cell
socal
cell
small
proport
ttreg
cell
lost
express
eae
induct
express
abil
mediat
eae
although
level
mrna
protein
decreas
ms
patient
unclear
whether
reflect
transit
cell
diseas
pathogenesi
thu
despit
extens
investig
phenotyp
function
characterist
treg
cell
sever
key
issu
await
elucid
better
understand
cell
contribut
immun
homeostasi
human
regardless
complex
natur
phenotyp
treg
subset
investig
indic
cell
function
impair
ms
patient
although
treg
subset
suppress
prolifer
respond
cell
product
interestingli
treg
subset
suppress
product
also
defect
ms
patient
sinc
cell
enrich
activ
ms
lesion
consid
crucial
ms
pathogenesi
data
suggest
compromis
treg
cell
function
may
exagger
diseas
symptom
observ
could
provid
possibl
mechanist
insight
control
ms
interestingli
impair
suppressor
function
treg
cell
also
note
without
numer
reduct
cell
peripher
blood
ms
patient
mention
impair
suppressor
function
correl
diminish
express
protein
mrna
ms
patient
diminish
suppress
mbpinduc
prolifer
peripher
cell
observ
untreat
ms
patient
paradox
associ
increas
frequenc
treg
cell
interestingli
abil
treg
cell
depress
relapsingremit
secondari
progress
ms
patient
despit
compar
number
phenotyp
cell
howev
statu
treg
cell
primari
progress
ms
neuron
deficit
accru
without
remiss
current
known
thu
studi
suggest
despit
variabl
number
phenotyp
diminish
suppressor
function
treg
cell
may
signific
impact
ms
pathogenesi
howev
clinic
valu
depress
suppressor
function
variou
treg
cell
challeng
treat
caution
uncertainti
function
aspect
human
treg
cell
attribut
technic
issu
associ
vitro
assay
system
use
function
assess
includ
type
stimul
respond
antibodi
antigen
present
cell
along
antibodi
vs
immobil
antibodi
block
product
maxim
suppress
case
differ
cellular
target
suppress
respond
cell
vs
antigen
present
cell
dendrit
cell
requir
enorm
number
treg
ratio
treg
cell
respond
lack
suitabl
anim
model
determin
suppress
activ
human
treg
cell
vivo
importantli
use
autolog
respond
treg
cell
hard
distinguish
acquisit
resist
respond
cell
treg
cellmedi
suppress
compromis
suppressor
function
treg
cell
technic
issu
render
result
vitro
suppress
assay
somewhat
uninterpret
sinc
difficult
determin
impact
phenotyp
defect
number
function
human
treg
cell
diseas
progress
long
durat
ms
correl
sought
paramet
health
statu
ms
patient
specif
time
point
major
diseasemodifi
treatment
avail
today
direct
relapsingremit
ms
pauciti
drug
treat
secondari
primari
progress
ms
treatment
ms
patient
reduc
relaps
without
alter
circul
number
treg
cell
anoth
studi
demonstr
treatment
relapsingremit
ms
patient
increas
proport
treg
cell
baselin
glatiram
acet
treatment
relapsingremit
ms
patient
reconstitut
treg
cell
increas
total
treg
cell
number
combin
treatment
glatiram
acet
reduc
number
treg
cell
without
affect
memori
type
treg
cell
chronic
ms
patient
glatiram
acet
treatment
ms
patient
improv
treg
cell
function
expand
cell
interestingli
treatment
redistribut
ttreg
subset
central
memorylik
treg
popul
express
increas
subset
express
mrna
natalizumab
monoclon
human
antibodi
target
chain
late
antigen
integrin
reduc
relaps
independ
alter
treg
cell
frequenc
function
although
diseasemodifi
therapi
glatiram
acet
natalizumab
reduc
relaps
ms
patient
provid
robust
protect
ms
revers
axon
degener
excit
appropri
determin
alter
number
function
treg
cell
variou
stage
diseas
treatment
effect
diseasemodifi
drug
becom
avail
posttransl
modif
histon
acetyl
phosphoryl
ubiquityl
power
epigenet
modul
substanti
influenc
gene
express
epigenet
marker
includ
acetyl
methyl
histon
cytosineguanosin
cpg
dinucleotid
methyl
report
locu
naiv
cell
activ
cell
adapt
treg
cell
natur
treg
cpg
dinucleotid
methyl
locu
propos
treg
cell
manipul
via
epigenet
modif
transcript
factor
mice
support
notion
shown
treatment
mice
tsa
enhanc
treg
cellmedi
suppress
homeostat
prolifer
decreas
inflammatori
bowel
diseas
conjunct
lowdos
rapamycin
tsa
induc
perman
treg
celldepend
cardiac
islet
allograft
surviv
donorspecif
allograft
toler
contrast
data
attrit
natur
occur
type
diabet
primari
progress
eae
autoimmunepron
nod
mice
tsa
treatment
associ
modul
treg
cell
function
global
gene
express
analysi
indic
downregul
mani
gene
uninduc
splenocyt
tsatreat
mice
includ
novel
proinflammatori
gene
specif
express
macrophag
transcript
unpublish
data
contrari
tsa
treatment
induc
histon
hyperacetyl
reduc
inflamm
demyelin
axon
damag
spinal
cord
interestingli
drug
treatment
diminish
gener
memori
cell
induc
antigenspecif
toler
fig
indic
abrog
tcell
prolifer
drain
lymph
node
cell
splenocyt
stimul
vitro
albeit
normal
prolifer
tcell
mitogen
howev
activ
restor
abil
toler
cell
respond
antigen
stimul
indic
revers
anergi
toler
character
reduc
antigeninduc
product
gmcsf
consecut
appear
doubl
produc
cell
occur
peripher
lymphoid
tissu
suscept
repress
tsa
treatment
cn
cell
appear
acut
phase
cell
cell
gmcsfexpress
cell
found
chronic
phase
importantli
tsa
treatment
diminish
frequenc
cell
cn
primari
progress
eae
model
tsa
treatment
also
reduc
abund
matur
neutrophil
secondari
lymphoid
tissu
influx
spinal
cord
thu
addit
myelinspecif
tcell
toler
induct
select
repress
matur
neutrophil
cell
critic
involv
epigenet
regul
primari
progress
eae
data
indic
epigenet
regul
histon
acetyl
amelior
autoimmun
diseas
type
diabet
eae
modul
gene
express
without
involv
treg
popul
transcript
interestingli
treatment
variou
small
molecul
inhibitor
histon
deacetylas
increas
suppress
function
freshli
isol
vitroexpand
human
treg
cell
function
chang
accompani
increas
express
neg
regul
immun
respons
indic
epigenet
drug
promis
pharmacolog
agent
improv
immunosuppress
potenti
lymphocyt
sinc
tsa
potent
inhibitor
histon
deacetylas
effect
revers
natur
occur
type
diabet
immunizationinduc
eae
without
caus
undesir
side
effect
strategi
may
potenti
use
treat
patient
autoimmun
administr
lipidlow
drug
atorvastatin
allevi
eae
without
increas
cell
treg
popul
implic
protect
neurodegener
observ
consist
abil
statin
inhibitor
cholesterol
biosynthesi
affect
cell
sinc
cell
pivot
ms
pathogenesi
inhibit
product
statin
could
use
treatment
ms
sinc
ms
consid
autoimmun
diseas
induct
antigenspecif
toler
best
approach
annihil
debilit
diseas
via
inactiv
autoreact
cell
without
caus
undesir
side
effect
ms
genet
predispos
selfreact
lymphocyt
recogn
neuron
antigen
context
hypothet
escap
thymic
delet
central
toler
subsequ
reactiv
peripher
antigenpres
cell
caus
dire
consequ
discuss
induct
anergi
could
restrain
autoreact
cell
caus
neuron
destruct
toward
goal
sever
clinic
trial
conduct
ms
patient
administ
peptid
deriv
mbp
mog
plp
via
variou
rout
ref
citat
therein
also
complex
hla
class
ii
molecul
myelin
peptid
plasmid
contain
mbp
protein
refer
dna
vaccin
attenu
autolog
cell
specif
mbp
mog
plp
candid
toler
induct
ms
patient
furthermor
peripher
blood
mononuclear
cell
coupl
seven
myelin
peptid
also
test
efficaci
produc
favor
outcom
ms
patient
surprisingli
oral
administr
mbp
fail
protect
ms
observ
previous
type
diabet
alter
ligand
peptid
analog
immunogen
peptid
modifi
interact
tcell
receptor
retain
abil
bind
hla
motif
prove
fatal
clinic
trial
although
approach
safeti
issu
breakthrough
clinic
benefit
achiev
recent
effort
establish
antigenspecif
toler
autoimmun
patient
includ
administr
tolerogen
dendrit
cell
tolerogen
immunemodifi
nanoparticl
far
success
toleranceinduc
strategi
emerg
standardofcar
clinic
use
identif
diseaseinstig
antigen
pave
way
success
design
antigenspecif
toler
treatment
debilit
cn
diseas
well
establish
peripher
toler
paramount
import
homeostat
control
tcell
repertoir
curtail
autoimmun
concert
effort
half
centuri
unravel
unexpectedli
divers
type
treg
cell
mous
analog
treg
cell
multipl
phenotyp
report
human
well
attempt
understand
mode
immunosuppress
mediat
cell
yield
clue
sever
mechan
need
care
discern
limit
studi
conduct
eae
model
support
vivo
manipul
treg
cell
mostli
thymicderiv
natur
occur
treg
cell
epigenet
pharmacolog
strategi
fig
although
diseasemodifi
therapi
provid
benefit
ms
patient
unclear
whether
diseas
protect
accompani
chang
treg
cell
number
phenotyp
function
adopt
uniform
paramet
evalu
phenotyp
marker
may
help
improv
understand
statu
treg
subset
variabl
prolong
durat
chronic
neurodegener
import
emphas
need
refin
vitro
condit
requir
assess
suppress
function
human
treg
cell
fact
treg
cell
scarc
brain
lesion
abund
cerebrospin
fluid
ms
patient
suggest
anatom
constraint
respons
uneven
distribut
treg
cell
essenti
know
whether
pharmacolog
intervent
administr
biolog
improv
ms
symptom
may
influenc
treg
cell
traffick
brain
final
sinc
treg
cell
produc
type
treg
also
report
impair
ms
patient
inform
whether
diseasemodifi
treatment
also
impact
cellular
compart
